序贯三联疗法与纳米银敷料治疗延迟就诊低温烧伤的疗效与经济性比较
回顾性队列研究纳入309例延迟就诊后进展为深度烧伤的小面积低温烧伤患者,比较银霜联合rhEGF及复方黄柏液三联疗法(联合组165例)与纳米银敷料方案(传统组144例)。联合组创面愈合时间更短、换药次数更少、疼痛评分更低,总费用与自付费用均显著低于传统组,两组感染率无统计学差异。
要点
- 联合组创面愈合时间显著短于传统组(28±4天 vs 41±5天,P<0.001)
- 联合组换药次数显著少于传统组(14±3次 vs 21±4次,P<0.001)
- 联合组总费用与自付费用均显著低于传统组(P<0.001)
核心结论
- 对小面积延迟就诊低温深度烧伤,联合方案在加速愈合、减轻疼痛和大幅降低经济负担方面显著优于传统纳米银方案,为理想选择。
研究设计与样本
- 联合组165例接受银霜、rhEGF与复方黄柏液三联疗法,传统组144例接受纳米银敷料方案。
主要发现
- 联合组愈合时间显著短于传统组(28±4天 vs 41±5天,P<0.001)。
- 联合组换药次数显著少于传统组(14±3次 vs 21±4次,P<0.001)。
- 联合组自第二次换药起疼痛评分显著低于传统组(P<0.05)。
- 两组创面感染率无统计学差异(2.4% vs 3.5%,P>0.05)。
- 联合组总费用与自付费用均显著低于传统组(总费用1508±360元 vs 3735±480元;自付302±72元 vs 1904±96元,P<0.001)。
临床怎么用
- 对延迟就诊后进展为深二度至三度的小面积低温烧伤,可优先考虑银霜、rhEGF与复方黄柏液三联方案以加速愈合、减少换药次数和降低费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the comprehensive efficacy of a triple therapy combining silver sulfadiazine cream, recombinant human epidermal growth factor (rhEGF), and Compound Huangbai Liquid (Combined Group) versus a nano-silver dressing regimen (Traditional Group) for small-area (<1% TBSA), low-temperature burns that progressed to deep burns due to delayed presentation. METHODS: A retrospective cohort study was conducted, enrolling 309 patients admitted between January 2023 and December 2024 who were diagnosed with deep second- to third-degree burns following delayed presentation after initial neglect of blisters. The Combined Group (n = 165) received the triple therapy, and the Traditional Group (n = 144) received the nano-silver dressing regimen. Wound healing time, frequency of dressing changes, VAS pain score, wound infection rate, and economic burden were evaluated. RESULTS: The wound healing time in the Combined Group was significantly shorter than in the Traditional Group (28 ± 4 days vs. 41 ± 5 days, P < 0.001), with fewer dressing changes (14 ± 3 times vs. 21 ± 4 times, P < 0.001). The pain scores were significantly lower in the Combined Group from the second dressing change onward (P < 0.05). There was no statistical difference in wound infection rates between the two groups (2.4% vs. 3.5%, P > 0.05). Further precise accounting showed that both the total cost and out-of-pocket expenses for patients in the Combined Group were significantly lower than those in the Traditional Group (Total cost: 1508 ± 360 CNY vs. 3735 ± 480 CNY; Out-of-pocket: 302 ± 72 CNY vs. 1904 ± 96 CNY, P < 0.001). CONCLUSION: For small-area, low-temperature deep burns that have worsened due to delayed presentation, the combined regimen demonstrates significant superiority over the traditional regimen in accelerating healing, reducing pain, and, most notably, drastically lowering the economic burden on patients through synergistic drug actions. It represents an ideal choice for addressing this clinical challenge.
引用
- Li S, Sun X, Sun W, et al. Comparative efficacy and economic impact of sequential triple therapy versus nano-silver dressings in delayed-presentation low-temperature burns: A retrospective cohort study. Burns. 2026. PMID: 42296882. doi:10.1016/j.burns.2026.108023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。